1132650-67-9 (氯化铵-15N,Lisinopril Cyclohexyl Analogue)

赖诺普利杂质F;氯化铵-15N;

Lisinopril Cyclohexyl Analog;Lisinopril Cyclohexyl Analogue;(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;Lisinopril impurity F;UNII-FJ10AC5C13;N2-((1S)-1-Carboxy-3-cyclohexylpropyl)-L-lysyl-L-proline;J-002929;Q27278011;Lisinopril specified impurity F;Lisinopril Imp. F (EP); (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]-pyrrolidine-2-carboxylic Acid; Lisinopril Cyclohexyl Analogue; N2-[(1S)-1-carboxy-3-cyclohexylpropyl]-L-lysyl-L-Proline;DTXSID00150332;(2S)-1-((2S)-6-Amino-2-(((1S)-1-carboxy-3-cyclohexylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid;1132650-67-9;FJ10AC5C13;(S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-cyclohexylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid;L-Proline, N2-((1S)-1-carboxy-3-cyclohexylpropyl)-L-lysyl-;LISINOPRIL IMPURITY F [EP IMPURITY];Lisinopril specified impurity F [EP];

QYSKCMYFYQRFSL-BZSNNMDCSA-N

1S/C21H37N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h15-18,23H,1-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1

O=C([C@H](CCCCN)N[C@H](C(=O)O)CCC1CCCCC1)N1CCC[C@H]1C(=O)O